Today: 21 May 2026
Ondas stock slips after SEC filing tees up more shares for resale in Sentry deal
8 January 2026
1 min read

Ondas stock slips after SEC filing tees up more shares for resale in Sentry deal

NEW YORK, Jan 8, 2026, 09:33 EST — Regular session

  • Ondas shares fell about 5% in early trading as investors parsed a fresh prospectus filing tied to its Sentry CS acquisition
  • The filing covers 1.67 million shares that can be resold by selling holders, not new stock sold by the company
  • Investors are looking to a Needham conference appearance on Jan. 14 and an Ondas investor day on Jan. 16

Ondas Holdings Inc shares slid in early U.S. trading on Thursday after the company filed paperwork registering more stock for potential resale tied to its acquisition of Israeli counter-drone firm Sentry CS. ONDS was down about 5% at $12.18 shortly after the open.

The filing matters now because Ondas has been issuing shares as part of a staged payment schedule for Sentry, and the registrations can make it easier for recipients to sell into the market. For thinly traded small caps, that possibility alone can move a stock.

A prospectus supplement dated Jan. 8 covers 1,671,899 shares held by “selling stockholders” and lays out additional cash-and-stock installments that could follow under the purchase agreement. Ondas said it paid $2.5 million in cash and issued the shares on Jan. 8 as part of that schedule. Ondas Holdings Inc.

The company is not raising money in this resale registration. “We will not receive any proceeds from the sale of the Shares by the selling stockholders,” the prospectus said. Ondas Holdings Inc.

Investors have also been eyeing a run of company events. Ondas said on Wednesday its CEO, Eric Brock, will join a fireside chat at the Needham Growth Conference on Jan. 14.

Ondas is set to host a virtual investor day on Jan. 16, where management has said it expects to provide an update on its 2026 business plan and financial outlook.

The risk for bulls is simple: more shares become eligible for resale just as the company is asking investors to look ahead to 2026. If selling holders move quickly — or if upcoming installments are paid in stock rather than cash — supply could weigh on the price, even without new operating news.

Stock Market Today

  • Sudarshan Colorants India's Earnings Show Potential Despite Profit Dip
    May 20, 2026, 8:53 PM EDT. Sudarshan Colorants India Limited (NSE:SUDARCOLOR) reported weaker profits last quarter, impacted by ₹50 million in unusual expenses that are unlikely to recur, suggesting potential profit rebound. The company's earnings per share (EPS) are growing strongly, indicating solid underlying business performance. Investors should consider balance sheet strength and monitor two identified warning signals, one considered significant. While profit was soft this time, analysts view Sudarshan Colorants' earnings outlook as cautiously optimistic, citing quality income statement elements and possible earnings improvements in the next quarter.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
EV Stocks Mixed in Premarket: Rivian Rises Despite Recall as Tesla, Lucid Slip
Previous Story

EV Stocks Mixed in Premarket: Rivian Rises Despite Recall as Tesla, Lucid Slip

Dow Jones Today: Dow steadies near record highs as jobs report looms and Trump defense talk jolts stocks
Next Story

Dow Jones Today: Dow steadies near record highs as jobs report looms and Trump defense talk jolts stocks

Go toTop